Rilonacept vs placebo
Number of participants experiencing an attacka · people with familial Mediterranean fever
Rilonacept showed no clear difference in number of participants experiencing an attacka compared with placebo (moderate certainty).
1 finding from 1 review
- Interventions for reducing inflammation in familial Mediterranean fever 2022 · Cochrane Headline outcomes onlyRR 0.87 [0.59, 1.26]1 study · 14 participantsModerate